Total planned funding: $166,441,688
Allocations
Countries/Regions
India | $166,441,688 |
Organizational Types
NGO | $65,200,670 |
Unknown | $38,184,736 |
Own Agency | $31,858,398 |
University | $16,382,112 |
Multi-lateral Agency | $3,510,000 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
FBO | $2,700,000 |
Host Country Government Agency | $1,539,200 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $71,979,597 |
Prevention | $37,580,736 |
Management and Operations | $22,561,043 |
Care | $19,455,581 |
Treatment | $7,997,353 |
Testing | $6,867,378 |
Budget Codes
OHSS: Health Systems Strengthening | $40,943,195 |
HVSI: Strategic Information | $23,040,285 |
HVMS: Management and Operations | $22,561,043 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,232,797 |
HBHC: Care: Adult Care and Support | $9,467,401 |
HLAB: Laboratory Infrastructure | $7,996,117 |
HTXS: Treatment: Adult Treatment | $7,195,728 |
HVCT: Testing: HIV Testing and Counseling | $6,867,378 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,465,097 |
HVTB: Care: TB/HIV | $4,700,025 |
HKID: Care: Orphans and Vulnerable Children | $4,332,086 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,631,504 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,112,090 |
HMBL: Biomedical Prevention: Blood Safety | $2,129,248 |
PDCS: Care: Pediatric Care and Support | $956,069 |
PDTX: Treatment: Pediatric Treatment | $778,148 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$37,560,247
Countries/Regions
FHI 360:
$22,152,182
Countries/Regions
USG Aggregated Agencies:
$21,290,331
Countries/Regions
Voluntary Health Services:
$12,460,000
Countries/Regions